Search Result "LDL receptor mutation"
The LDL-Receptor and its Molecular Properties: From Theory to Novel Biochemical and Pharmacological Approaches in Reducing LDL-cholesterol
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 2 Year: 2020 Page: 317-333
Author(s): Dimitrios Petroglou,Ilias Kanellos,Christos Savopoulos,Georgia Kaiafa,Anastasios Chrysochoou,Panagiotis Skantzis,Stylianos Daios,Apostolos I. Hatzitolios,Georgios Giannoglou
MicroRNA-mediated Regulation of LDL Receptor: Biological andPharmacological Implications
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 14 Year: 2024 Page: 1830-1838
Author(s): Ali H. Eid
Further LDL Cholesterol Lowering Through Targeting PCSK9 for Coronary Artery Disease
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 8 Issue: 4 Year: 2008 Page: 238-243
Author(s): Guoqing Cao, Yue-Wei Qian, Mark C. Kowala, Robert J. Konrad
Regulation of the Urokinase Receptor (uPAR) by LDL Receptor-related Protein-1 (LRP1)
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1962-1969
Author(s): Steven L. Gonias, Alban Gaultier, Minji Jo
LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6249-6255
Author(s): Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo, Ron C. Hoogeveen
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and LDL Lowering in the Contemporary Management of Dyslipidemia
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2013 Page: 281-288
Author(s): Maryna Popp Switzer,Azikiwe C. Nwosu,Zinnia San Juan,Debabrata Mukherjee
Recent Patents on PCSK9: A New Target for Treating Hypercholesterolemia
Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 3 Issue: 3 Year: 2009 Page: 201-212
Author(s): Hai Li, Haixia Li, Nick Ziegler, Rutao Cui, Jingwen Liu
Regulatory Effects of Peptides from the Pro and Catalytic Domains of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) on Low-Density Lipoprotein Receptor (LDL-R)
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2168-2182
Author(s): H. Palmer-Smith, A. Basak
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Oxidized LDL Antibodies in Treatment and Risk Assessment of Atherosclerosis and Associated Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1021-1030
Author(s): Jan Nilsson, Gunilla Nordin Fredrikson, Alexandru Schiopu, Prediman K. Shah, Bo Jansson, Roland Carlsson